Novel genomic techniques open new avenues in the analysis of monogenic disorders

The molecular genetic cause of over 3,000 monogenic disorders is currently unknown. This review discusses how novel genomic techniques like Next‐Generation DNA Sequencing (NGS) and genotyping arrays open new avenues in the elucidation of genetic defects causing monogenic disorders. They will not only speed up disease gene identification but will enable us to systematically tackle previously intractable monogenic disorders. These are mainly disorders not amenable to classic linkage analysis, for example, due to insufficient family size. Most monogenic diseases are caused by exonic mutations or splice‐site mutations changing the amino acid sequence of the affected gene. These mutations can be identified by sequencing of all exons in the human genome (exome sequencing) rendering whole genome sequencing unnecessary in most cases. Genotyping arrays containing 105–2×106 single nucleotide polymorphisms (SNPs) and nonpolymorphic markers allow highly accurate mapping of genomic deletions and duplications not detectable by exome sequencing, which are the second most common cause of monogenic disorders. However, several hundred rare, previously unknown sequence variants affecting the amino acid sequence of the encoded protein are found in the exome of every human individual. Therefore, the main challenge will be the differentiation between the many rare benign variants detected by novel genomic techniques and disease causing mutations. Hum Mutat 32:144–151, 2011. © 2011 Wiley‐Liss, Inc.

[1]  Sebastian Bauer,et al.  Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome , 2010, Nature Genetics.

[2]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[3]  Anne E Carpenter,et al.  Visualization of image data from cells to organisms , 2010, Nature Methods.

[4]  C. Wider,et al.  Genetics of essential tremor. , 2012, Parkinsonism & related disorders.

[5]  L. Biesecker.  Exome sequencing makes medical genomics a reality , 2010, Nature Genetics.

[6]  M. Rivas,et al.  Nature Genetics Advance Online Publication High-throughput, Pooled Sequencing Identifies Mutations in Nubpl and Foxred1 in Human Complex I Deficiency , 2022 .

[7]  K. Gunderson,et al.  High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. , 2006, Genome research.

[8]  J. Casanova,et al.  Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma , 2010, The Journal of experimental medicine.

[9]  D. Botstein,et al.  Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease , 2003, Nature Genetics.

[10]  M. Nachman,et al.  Estimate of the mutation rate per nucleotide in humans. , 2000, Genetics.

[11]  Christian E Elger,et al.  15q13.3 microdeletions increase risk of idiopathic generalized epilepsy , 2009, Nature Genetics.

[12]  Andrew Menzies,et al.  A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation , 2009, Nature Genetics.

[13]  P. Bork,et al.  Human non-synonymous SNPs: server and survey. , 2002, Nucleic acids research.

[14]  S. Henikoff,et al.  Predicting the effects of amino acid substitutions on protein function. , 2006, Annual review of genomics and human genetics.

[15]  P. Stankiewicz,et al.  A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes , 2009, Nature Genetics.

[16]  M. Spence,et al.  Analysis of human genetic linkage , 1986 .

[17]  Christian Gilissen,et al.  Exome sequencing identifies WDR35 variants involved in Sensenbrenner syndrome. , 2010, American journal of human genetics.

[18]  G. Kuhlenbäumer,et al.  Clinical features and molecular genetics of hereditary peripheral neuropathies , 2002, Journal of Neurology.

[19]  Christine Klein,et al.  LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. , 2006, The New England journal of medicine.

[20]  D. Summerer.  Enabling technologies of genomic-scale sequence enrichment for targeted high-throughput sequencing. , 2009, Genomics.

[21]  Naomichi Matsumoto,et al.  De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy , 2008, Nature Genetics.

[22]  Stephan J Sanders,et al.  Whole exome sequencing identifies recessive WDR62 mutations in severe brain malformations , 2010, Nature.

[23]  P. Shannon,et al.  Exome sequencing identifies the cause of a Mendelian disorder , 2009, Nature Genetics.

[24]  Margaret A. Pericak-Vance,et al.  Exome Sequencing of a Multigenerational Human Pedigree , 2009, PloS one.

[25]  Charles Lee,et al.  Genome-wide detection of human copy number variations using high-density DNA oligonucleotide arrays. , 2006, Genome research.

[26]  David Haussler,et al.  Improved splice site detection in Genie , 1997, RECOMB '97.

[27]  Markus Perola,et al.  Lessons from studying monogenic disease for common disease. , 2006, Human molecular genetics.

[28]  Nicholette D. Palmer,et al.  Molecular basis of a linkage peak: exome sequencing and family-based analysis identify a rare genetic variant in the ADIPOQ gene in the IRAS Family Study. , 2010, Human molecular genetics.

[29]  Jay Shendure,et al.  Identification by whole-genome resequencing of gene defect responsible for severe hypercholesterolemia , 2010, Human molecular genetics.

[30]  M. Marra,et al.  Massively parallel sequencing: the next big thing in genetic medicine. , 2009, American journal of human genetics.

[31]  Sean D. Mooney,et al.  Bioinformatics approaches and resources for single nucleotide polymorphism functional analysis , 2005, Briefings Bioinform..

[32]  Martin Dufva,et al.  Introduction to Microarray Technology , 2018, Predictive Biomarkers in Oncology.

[33]  Emily H Turner,et al.  Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome , 2010, Nature Genetics.

[34]  Francis S. Collins,et al.  Positional cloning moves from perditional to traditional , 1995, Nature Genetics.

[35]  P. Pollak,et al.  LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. , 2006, The New England journal of medicine.

[36]  Jay Shendure,et al.  Methods for genomic partitioning. , 2009, Annual review of genomics and human genetics.

[37]  Nilüfer Ertekin-Taner,et al.  Genetics of Alzheimer's disease: a centennial review. , 2007, Neurologic clinics.

[38]  Nada Jabado,et al.  Unexpected allelic heterogeneity and spectrum of mutations in Fowler syndrome revealed by next‐generation exome sequencing , 2010, Human mutation.

[39]  Christian Gilissen,et al.  De novo mutations of SETBP1 cause Schinzel-Giedion syndrome , 2010, Nature Genetics.

[40]  Erika Check Hayden.  Genomics shifts focus to rare diseases. , 2009, Nature.

[41]  Timothy B. Stockwell,et al.  Genetic Variation in an Individual Human Exome , 2008, PLoS genetics.

[42]  E. Mardis.  The impact of next-generation sequencing technology on genetics. , 2008, Trends in genetics : TIG.

[43]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[44]  P. Stankiewicz,et al.  Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. , 2010, The New England journal of medicine.

[45]  S. Levy,et al.  Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy , 2010, Nature Genetics.

[46]  Emily H Turner,et al.  Targeted Capture and Massively Parallel Sequencing of Twelve Human Exomes , 2009, Nature.